542 related articles for article (PubMed ID: 26619808)
1. APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.
Vélez JI; Lopera F; Sepulveda-Falla D; Patel HR; Johar AS; Chuah A; Tobón C; Rivera D; Villegas A; Cai Y; Peng K; Arkell R; Castellanos FX; Andrews SJ; Silva Lara MF; Creagh PK; Easteal S; de Leon J; Wong ML; Licinio J; Mastronardi CA; Arcos-Burgos M
Mol Psychiatry; 2016 Jul; 21(7):916-24. PubMed ID: 26619808
[TBL] [Abstract][Full Text] [Related]
2. Familial Alzheimer's Disease and Recessive Modifiers.
Vélez JI; Lopera F; Silva CT; Villegas A; Espinosa LG; Vidal OM; Mastronardi CA; Arcos-Burgos M
Mol Neurobiol; 2020 Feb; 57(2):1035-1043. PubMed ID: 31664702
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred.
Pastor P; Roe CM; Villegas A; Bedoya G; Chakraverty S; García G; Tirado V; Norton J; Ríos S; Martínez M; Kosik KS; Lopera F; Goate AM
Ann Neurol; 2003 Aug; 54(2):163-9. PubMed ID: 12891668
[TBL] [Abstract][Full Text] [Related]
4. Targeting Neuroplasticity, Cardiovascular, and Cognitive-Associated Genomic Variants in Familial Alzheimer's Disease.
Vélez JI; Lopera F; Creagh PK; Piñeros LB; Das D; Cervantes-Henríquez ML; Acosta-López JE; Isaza-Ruget MA; Espinosa LG; Easteal S; Quintero GA; Silva CT; Mastronardi CA; Arcos-Burgos M
Mol Neurobiol; 2019 May; 56(5):3235-3243. PubMed ID: 30112632
[TBL] [Abstract][Full Text] [Related]
5. A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer's Disease.
Vélez JI; Rivera D; Mastronardi CA; Patel HR; Tobón C; Villegas A; Cai Y; Easteal S; Lopera F; Arcos-Burgos M
Neural Plast; 2016; 2016():9760314. PubMed ID: 26949549
[TBL] [Abstract][Full Text] [Related]
6. E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles.
Lendon CL; Martinez A; Behrens IM; Kosik KS; Madrigal L; Norton J; Neuman R; Myers A; Busfield F; Wragg M; Arcos M; Arango Viana JC; Ossa J; Ruiz A; Goate AM; Lopera F
Hum Mutat; 1997; 10(3):186-95. PubMed ID: 9298817
[TBL] [Abstract][Full Text] [Related]
7. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
8. Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women.
Corbo RM; Gambina G; Ulizzi L; Monini P; Broggio E; Rosano A; Scacchi R
Dement Geriatr Cogn Disord; 2007; 24(2):82-5. PubMed ID: 17565217
[TBL] [Abstract][Full Text] [Related]
9. Presenilin 1 polymorphism associated with Alzheimer's disease in apolipoprotein E4 carriers.
Martínez-García A; Aldudo J; Recuero M; Sastre I; Vilella-Cuadrada E; Rosich-Estragó M; Frank A; Valdivieso F; Bullido MJ
Dement Geriatr Cogn Disord; 2008; 26(5):440-4. PubMed ID: 18957849
[TBL] [Abstract][Full Text] [Related]
10.
Quiroz YT; Aguillon D; Aguirre-Acevedo DC; Vasquez D; Zuluaga Y; Baena AY; Madrigal L; Hincapié L; Sanchez JS; Langella S; Posada-Duque R; Littau JL; Villalba-Moreno ND; Vila-Castelar C; Ramirez Gomez L; Garcia G; Kaplan E; Rassi Vargas S; Ossa JA; Valderrama-Carmona P; Perez-Corredor P; Krasemann S; Glatzel M; Kosik KS; Johnson K; Sperling RA; Reiman EM; Sepulveda-Falla D; Lopera F; Arboleda-Velasquez JF
N Engl J Med; 2024 Jun; 390(23):2156-2164. PubMed ID: 38899694
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease and apolipoprotein E-4 allele in an Amish population.
Pericak-Vance MA; Johnson CC; Rimmler JB; Saunders AM; Robinson LC; D'Hondt EG; Jackson CE; Haines JL
Ann Neurol; 1996 Jun; 39(6):700-4. PubMed ID: 8651641
[TBL] [Abstract][Full Text] [Related]
12. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study.
Acosta-Baena N; Sepulveda-Falla D; Lopera-Gómez CM; Jaramillo-Elorza MC; Moreno S; Aguirre-Acevedo DC; Saldarriaga A; Lopera F
Lancet Neurol; 2011 Mar; 10(3):213-20. PubMed ID: 21296022
[TBL] [Abstract][Full Text] [Related]
13. Association of APOE e2 genotype with Alzheimer's and non-Alzheimer's neurodegenerative pathologies.
Goldberg TE; Huey ED; Devanand DP
Nat Commun; 2020 Sep; 11(1):4727. PubMed ID: 32948752
[TBL] [Abstract][Full Text] [Related]
14. Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease.
Le Guen Y; Belloy ME; Grenier-Boley B; de Rojas I; Castillo-Morales A; Jansen I; Nicolas A; Bellenguez C; Dalmasso C; Küçükali F; Eger SJ; Rasmussen KL; Thomassen JQ; Deleuze JF; He Z; Napolioni V; Amouyel P; Jessen F; Kehoe PG; van Duijn C; Tsolaki M; Sánchez-Juan P; Sleegers K; Ingelsson M; Rossi G; Hiltunen M; Sims R; van der Flier WM; Ramirez A; Andreassen OA; Frikke-Schmidt R; Williams J; Ruiz A; Lambert JC; Greicius MD; ; Arosio B; Benussi L; Boland A; Borroni B; Caffarra P; Daian D; Daniele A; Debette S; Dufouil C; Düzel E; Galimberti D; Giedraitis V; Grimmer T; Graff C; Grünblatt E; Hanon O; Hausner L; Heilmann-Heimbach S; Holstege H; Hort J; Jürgen D; Kuulasmaa T; van der Lugt A; Masullo C; Mecocci P; Mehrabian S; de Mendonça A; Moebus S; Nacmias B; Nicolas G; Olaso R; Papenberg G; Parnetti L; Pasquier F; Peters O; Pijnenburg YAL; Popp J; Rainero I; Ramakers I; Riedel-Heller S; Scarmeas N; Scheltens P; Scherbaum N; Schneider A; Seripa D; Soininen H; Solfrizzi V; Spalletta G; Squassina A; van Swieten J; Tegos TJ; Tremolizzo L; Verhey F; Vyhnalek M; Wiltfang J; Boada M; García-González P; Puerta R; Real LM; Álvarez V; Bullido MJ; Clarimon J; García-Alberca JM; Mir P; Moreno F; Pastor P; Piñol-Ripoll G; Molina-Porcel L; Pérez-Tur J; Rodríguez-Rodríguez E; Royo JL; Sánchez-Valle R; Dichgans M; Rujescu D
JAMA Neurol; 2022 Jul; 79(7):652-663. PubMed ID: 35639372
[TBL] [Abstract][Full Text] [Related]
15. Mutations modifying sporadic Alzheimer's disease age of onset.
Vélez JI; Lopera F; Patel HR; Johar AS; Cai Y; Rivera D; Tobón C; Villegas A; Sepulveda-Falla D; Lehmann SG; Easteal S; Mastronardi CA; Arcos-Burgos M
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1116-1130. PubMed ID: 27573710
[TBL] [Abstract][Full Text] [Related]
16. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
17. Precuneus Failures in Subjects of the PSEN1 E280A Family at Risk of Developing Alzheimer's Disease Detected Using Quantitative Electroencephalography.
Ochoa JF; Alonso JF; Duque JE; Tobón CA; Baena A; Lopera F; Mañanas MA; Hernández AM
J Alzheimers Dis; 2017; 58(4):1229-1244. PubMed ID: 28550254
[TBL] [Abstract][Full Text] [Related]
18. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
[TBL] [Abstract][Full Text] [Related]
20. Allelic association but only weak evidence for linkage to the apolipoprotein E locus in late-onset Swedish Alzheimer families.
Liu L; Forsell C; Lilius L; Axelman K; Corder EH; Lannfelt L
Am J Med Genet; 1996 May; 67(3):306-11. PubMed ID: 8725748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
